# Helixmith

Helixmith is an Asset Manager based in Seoul, South Korea.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Seoul, South Korea
- **Region:** Asia
- **Address:** Seoul, South Korea
- **Assets under management:** Undisclosed
- **Website:** helixmith.com
- **LinkedIn:** https://www.linkedin.com/company/helixmith

## Regulatory record

- **Reports private funds:** No

## About

Helixmith (KOSDAQ: 084990) is a biotechnology company founded in 1996 in Seoul, South Korea. It develops gene therapies, biopharmaceuticals, novel biologics, and herbal therapeutics for diseases such as diabetic foot ulcers, claudication, and amyotrophic lateral sclerosis. The company offers solutions for previously untreated conditions.

## Questions

### What can be confirmed about Helixmith's investment focus?

Nothing. Helixmith's website is gated behind a human-verification process that blocks automated research tools. No primary-source interviews, regulatory filings, or published investor letters have surfaced to confirm its strategy, sector preferences, or asset-class exposure.

### Who runs Helixmith?

That is unknown. The firm's website, protected behind a bot-detection gate, is the only accessible public source, and it does not reveal team rosters, founder names, or leadership titles on indexed pages. No alternative primary source fills this gap.

## Related profiles

- [Helios Financial Services](https://altss.com/profile/helios-financial-services-llc)
- [Help.Capital](https://altss.com/profile/helpcapital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/helixmith

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology